Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing.
1. New information identifying nucleotide alterations of human butyrylcholinesterase allows the use of more specific nomenclature for the variants commonly known as atypical, fluoride, silent, and K variant. 2. In addition to suggesting a system of trivial names and abbreviations, we provide a list of formal names that follow the guidelines of the Committee for Human Gene Nomenclature. 3. It is suggested that formal names be included in publications whenever possible.
La Du
B N
BN
Pharmacology Department, University of Michigan Medical School, Ann Arbor 48109-0626.
Bartels
C F
CF
Nogueira
C P
CP
Arpagaus
M
M
Lockridge
O
O
D000595:Amino Acid Sequence; D002091:Butyrylcholinesterase / Q000145:classification* / Q000235:genetics; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004247:DNA / Q000235:genetics; D005796:Genes; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012969:Sodium Fluoride / Q000494:pharmacology; D013379:Substrate Specificity; D009626:Terminology as Topic
D002800:Cholinesterase Inhibitors; D012969:Sodium Fluoride; D004247:DNA; D002091:Butyrylcholinesterase